Argenx Se (ARGX) Long-Term Deferred Tax (2016 - 2025)

Argenx Se (ARGX) posted Long-Term Deferred Tax of $1.3 billion for Q4 2025, down 99.86% on a QoQ basis from $899.6 billion in Q2 2025, and up 40.2% year-over-year from $924.3 million in Q4 2024.

Argenx Se (ARGX) Long-Term Deferred Tax (2016 - 2025) Analysis & Trends

Argenx Se's Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $1.3 billion for Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 40.2% year-over-year to $1.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 billion (up 40.2% YoY) and the FY2025 annual result came in at $1.3 billion, up 40.2% from the prior year.
  • Long-Term Deferred Tax was $1.3 billion for Q4 2025 at Argenx Se, down from $899.6 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $899.6 billion in Q2 2025 and bottomed at $16.3 million in Q2 2021.
  • A 5-year average of $90.2 billion and a median of $118.0 million in 2023 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2023 — Long-Term Deferred Tax advanced 22.71% — and 2025, when it jumped 515062.12%.
  • Argenx Se's Long-Term Deferred Tax stood at $32.2 million in 2021, then jumped by 146.1% to $79.2 million in 2022, then advanced by 22.71% to $97.2 million in 2023, then surged by 850.82% to $924.3 million in 2024, then soared by 40.2% to $1.3 billion in 2025.
  • Business Quant data shows ARGX's Long-Term Deferred Tax at $1.3 billion in Q4 2025, $899.6 billion in Q2 2025, and $924.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.30 Bn
Jun 30, 2025 899.61 Bn
Dec 31, 2024 924.30 Mn
Jun 30, 2024 174.63 Mn
Dec 31, 2023 97.21 Mn
Jun 30, 2023 138.77 Mn
Dec 31, 2022 79.22 Mn
Jun 30, 2022 54.27 Mn
Dec 31, 2021 32.19 Mn
Jun 30, 2021 16.25 Mn
Dec 31, 2020 14.61 Mn
Dec 31, 2019 44.28 Mn
Dec 31, 2018 33.44 Mn
Dec 31, 2017 33.44 Mn
Dec 31, 2016 7.13 Mn